Dennis Bourdette, M.D.

Dr. Bourdette is professor emeritus, former chair (2000-2019) and founding director, Multiple Sclerosis and Neuroimmunology Center of the OHSU Department of Neurology. He received his neurology training at OHSU and completed a three-year post-doctoral fellowship at the Portland VAMC in neuroimmunology. He joined the Department of Neurology in 1985. Dr. Bourdette is nationally recognized for his research in the field of multiple sclerosis, has had research grants the National Institutes of Health, Department of Veterans Affairs, National MS Society, the Nancy Davis Foundation for Multiple Sclerosis and biotechnology companies. He has published over 270 articles mainly related to the development of treatments for multiple sclerosis.  He currently is focusing his research on treatments to stimulate remyelination in multiple sclerosis and  developing the anti-oxidant, lipoic acid, for treatment of multiple sclerosis. Dr. Bourdette holds an M.D. from the University of California at Davis.